ESMO Breast Cancer 2026 Highlights: Saci-IO HR+ - Summary - MDSpire

ESMO Breast Cancer 2026 Highlights: Saci-IO HR+

Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD discuss results from the Saci-IO HR+ trial, which were presented at the 2026 ESMO Breast Cancer Congress.

  • June 26, 2026

Share

Objective:

To discuss the results from the Saci-IO HR+ trial presented at the 2026 ESMO Breast Cancer Congress.

Approach:
  • Discussion: Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD provide insights on the trial findings.
Interpretation:

Conclusion:

Original Source(s)

ESMO Breast Cancer 2026 Highlights: Saci-IO HR+

  • June 26, 2026

Related Content

Primary endoscopic nasopharyngectomy for nasopharyngeal carcinoma: systematic review & meta-analysis

Diagnostic accuracy of imaging modalities for primary small-bowel tumors: a systematic review and diagnostic test accuracy meta-analysis

Navigating specific targets of psychoneurological symptom cluster in breast cancer: a computer-simulated network analysis